Three murine monoclonal antibodies (MAb), E19, E205, and E251, raised against pertussis toxin reacted in Western blots (immunoblots) with the Si, S4, and S2-S3 subunits, respectively, and neutralized the Chinese hamster ovary cell-clustering activity of pertussis toxin. MAb E251 recognized a linear synthetic peptide corresponding to amino acids 107 to 120 of the S2 subunit, suggesting a role for this region in receptor binding.
the subunits was recognized by MAb E205, the reaction was repeated with purified S4 and S5; this revealed that E205 recognizes the S4 subunit of PT (Fig. 1B) . E19, E205, and E251 were subclassed by use of an MAb subclassing kit (Dianova) as immunoglobulin Gl heavy-chain and kappa light-chain antibodies (results not shown). The three anti-PT antibodies were purified from hybridoma supernatant fluids by using a Pharmacia protein A-Sepharose CL-4B column (4) . The antibody preparations consisted of a 26-kDa lightchain band and a 55-kDa heavy-chain band after electrophoresis (data not shown). All three MAb neutralized PT clustering of CHO cells, whereas antibody 13C4 (28), directed against the B subunit of Shiga-like toxin, did not (Table 1) .
The ability of MAb E19 to inhibit the ADP ribosylation of bovine transducin was compared with that of rabbit polyclonal anti-Si antiserum. The MAb (1.1 mg/ml) or antiserum was serially diluted in phosphate-buffered saline, and 20 ,ul of each antibody dilution was incubated with 1 ,ul of PT (0.1 ,ug/ml) for 30 min at room temperature. After toxin activation by the addition of 5 (Fig. 2) .
The epitope recognized by MAb E251 was identified by screening for binding to a bank of synthetic peptides corresponding to regions of the S2 subunit protein sequence predicted to contain surface-exposed hydrophilic ,B turns (25, 26 tide or its bovine serum albumin (BSA) conjugate was used to coat the ELISA plate (Fig. 3) . Previous work employing antibodies raised against peptides as sequence-specific probes for the localization of the receptor-binding pocket of PT suggested involvement of amino acid residues 1 to 7, 35 to 59, and 91 to 106 of the S2 subunit (25, 26) and corresponding regions in the S3 subunit (24) .
Numerous PT-specific MAb have been obtained (1, 5, 6, 11, 14, (20) (21) (22) 27 ), but few have been characterized with respect to their ability to interfere with PT binding activity (5, 14) . Frank and Parker (6) described an S2-reactive MAb which did not neutralize PT in an in vivo histamine-sensitiz- ' . 4   FIG. 3 . Determination of the epitope recognized by MAb E251. An ELISA of BSA-conjugated peptides (hatched bars) and free peptides (filled bars) with E251 as the primary antibody (undiluted hybridoma supernatant) is shown. The peptides correspond to regions of the S2 subunit protein sequence and have been described elsewhere (25, 26) . Undiluted hybridoma supernatant from E55, which bound the S2 and S3 subunits of PT in Western blots but did not neutralize CHO cell-clustering activity, did not bind any of the peptides tested (results not shown). izing MAb reported thus far has been mapped. Here we report localization of the binding site of the inhibitory MAb E251 to amino acids 107 to 120 of the S2 subunit, which is adjacent to the segment of S2 previously implicated in receptor recognition (25) . Interestingly, in an ELISA, E251 recognizes the corresponding segment of the S3 subunit containing amino acids 104 to 117 only very weakly as a free peptide and not at all when the peptide is conjugated to BSA (results not shown). The core region of the two peptides differs only by a conservative alanine (S3) to serine (S2) exchange at position 113.
The identification of regions that are involved in the biological activity of PT not only provides insights into the structure-function relationship of the toxin molecule but also specifies epitopes in which an immune response may play an important role in protection. This, combined with recent advances in the "humanization" of murine MAb (29) , should lead to the production of anti-PT antibodies applicable to humans that may prove effective in providing passive protection (21) against pertussis in the nonimmunized newborn.
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